Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
24
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
9
users have commented on this narrative
25
users have followed this narrative
11 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
CytomX Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Late-Stage Trials And Partnerships Will Advance Precision Medicine Despite Setbacks
Key Takeaways Success of clinical candidates and unique tumor-targeting technology could enable regulatory progress, commercial expansion, and attract additional partnerships and licensing agreements. Increasing global cancer rates and strategic industry collaborations support diversified revenue streams, improved cash flow, and long-term growth opportunities.
View narrative
US$5.75
FV
63.1% undervalued
intrinsic discount
-31.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
2 days ago
author updated this narrative
Bankwell Financial Group
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Technology Investments And SBA Expansion Will Advance Community Banking
Key Takeaways Expansion of deposit teams and digital efficiencies are strengthening growth, reducing funding costs, and improving profitability while broadening market reach. Enhanced SBA lending, better asset quality, and favorable market dynamics are diversifying income streams and supporting sustainable long-term revenue growth.
View narrative
US$45.00
FV
7.4% undervalued
intrinsic discount
28.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
GMRA
GMR Airports
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Airport Expansions At Hyderabad And Mopa Will Increase Future Passenger Traffic
Key Takeaways Expansion projects and improved tariffs at key airports likely enhance revenue and earnings growth for GMR Airports. Non-aero revenue and reduced debt costs position the company for stronger profitability.
View narrative
₹95.50
FV
6.2% undervalued
intrinsic discount
24.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
2 days ago
author updated this narrative
SolarEdge Technologies
AN
AnalystConsensusTarget
Consensus Narrative from 25 Analysts
US Credits And Battery Storage Will Drive Change Amid Challenges
Key Takeaways Looming U.S. policy changes, rising competition, and market uncertainty threaten growth prospects, margins, and net income recovery despite current optimism. Margin expansion and commercial storage adoption are challenged by volatile costs, weakened distribution, and aggressive industry pricing pressures.
View narrative
US$19.64
FV
74.7% overvalued
intrinsic discount
20.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
45
users have followed this narrative
8 days ago
author updated this narrative
Holcim
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Aggressive Projections Will Falter Amid Regulatory And Market Risks
Key Takeaways High expectations for demand growth and margin expansion may be difficult to meet if market, regulatory, or competitive conditions shift unfavorably. Risks around regulatory costs, disruptive new materials, and integration of acquisitions could undermine profitability and long-term growth assumptions.
View narrative
CHF 66.02
FV
1.6% overvalued
intrinsic discount
-11.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
37
users have followed this narrative
2 days ago
author updated this narrative
Apcotex Industries
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Global Export Improvements And Capacity Expansions Will Define Future Success
Key Takeaways Focus on specialty, eco-friendly products and operational efficiency is set to improve profit margins and drive sustainable earnings growth. Global diversification and supportive government policies could boost revenue and market share amid rising demand and capacity expansion.
View narrative
₹437.50
FV
9.8% undervalued
intrinsic discount
13.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
9 days ago
author updated this narrative
10x Genomics
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts
Advanced Genomics Tools Will Shape Future Precision Medicine
Key Takeaways Expansion of product offerings and strategic acquisitions are enhancing innovation, reducing operational costs, and solidifying leadership in advanced genomics tools. Growth in global partnerships and improved international presence are increasing market opportunities and supporting resilient, long-term revenue streams.
View narrative
US$15.08
FV
5.2% undervalued
intrinsic discount
2.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
9 days ago
author updated this narrative
YPF Sociedad Anónima
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Vaca Muerta Expansion Will Unlock Long Term Export Potential
Key Takeaways Expansion into low-cost unconventional reserves and digital efficiency initiatives are driving higher output, operational improvements, and stronger profitability. Strategic midstream investments and a shift toward pure-play unconventional assets enhance export potential and position YPF for long-term resiliency in global energy markets.
View narrative
AR$57.10k
FV
25.6% undervalued
intrinsic discount
8.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
2 days ago
author updated this narrative
Gates Industrial
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Future Data Center Cooling And Mobility Will Unlock Global Markets
Key Takeaways Strong demand and innovation in multiple markets, including data centers and personal mobility, are powering revenue growth and margin expansion opportunities. Strategic R&D investment, geographic diversification, and improved balance sheet flexibility support long-term market share gains and enhanced profitability.
View narrative
US$29.80
FV
15.3% undervalued
intrinsic discount
4.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Value any company in seconds
Popular companies